Cellply is developing a revolutionary analytical platform for immune cell profiling of cellular function required in cell therapy and antibody development.
The Cellply Co-Culture Array (CCATM) technology offers a dramatically improved understanding of cell function at the single cell level with applicability across all stages of R&D into clinical development and manufacturing.
Contact us today to understand how we combine robotics, CCATM microfluidics and AI to significantly reduce your time to market at lower costs with less risk of failure.